Literature DB >> 10391178

Population-based study of the incidence of Shigella diarrhea and causative serotypes in Santiago, Chile.

V Prado1, R Lagos, J P Nataro, O San Martin, C Arellano, J Y Wang, A A Borczyk, M M Levine.   

Abstract

BACKGROUND: Shigella is an important cause of diarrheal disease in children in developing countries. The increasing prevalence of antibiotic-resistant strains has stimulated interest in the use of multivalent Shigella vaccines. Because Shigella vaccines under development are based on eliciting immunity to O antigens, monitoring the distribution of serotypes in defined target populations is critical. We initiated health center-based surveillance in a poor semirural community in Colina, Santiago (7489 children <60 months of age) to determine the age-specific incidence of Shigella disease and the responsible serotypes.
FINDINGS: Surveillance was maintained at the 2 health centers during warm seasons (November 1 through April 30) for 4 successive years (1994 to 1998). Shigella was recovered from 54 of 243 cases of dysentery (22%) and from 215 of 3966 cases of nondysenteric diarrhea (5.4%) (P < 0.001). The peak mean annual incidence of shigellosis occurred among children 12 to 47 months of age (9.0 to 12.6 cases/10(3) children), although the incidence in infants (5.2/10(3)) and children 48 to 59 months of age (6.2/10(3)) was also substantial. During the 1995 through 1996 season, an age-matched healthy control was cultured for every child <60 months of age with diarrhea. Shigella isolation from cases (34 of 576, 5.9%) was >8-fold higher than controls (4 of 576, 0.7%) (P < 0.01). Four serotypes, Shigella sonnei (45%), Shigella flexneri 2b (19%), S. flexneri 2a (14%) and S. flexneri 6 (11%), accounted for 89% of all cases.
INTERPRETATION: Shigella remains an important pediatric pathogen in Santiago. The serotype distribution from Colina, which closely resembles data from a population-based surveillance study in Santiago in the mid-1980s, demonstrates a remarkable degree of serotype stability in Santiago during a 15-year period.

Entities:  

Mesh:

Year:  1999        PMID: 10391178     DOI: 10.1097/00006454-199906000-00005

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  7 in total

Review 1.  Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road.

Authors:  Myron M Levine; Karen L Kotloff; Eileen M Barry; Marcela F Pasetti; Marcelo B Sztein
Journal:  Nat Rev Microbiol       Date:  2007-07       Impact factor: 60.633

2.  Defining the phylogenomics of Shigella species: a pathway to diagnostics.

Authors:  Jason W Sahl; Carolyn R Morris; Jennifer Emberger; Claire M Fraser; John Benjamin Ochieng; Jane Juma; Barry Fields; Robert F Breiman; Matthew Gilmour; James P Nataro; David A Rasko
Journal:  J Clin Microbiol       Date:  2015-01-14       Impact factor: 5.948

3.  A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology.

Authors:  Lorenz von Seidlein; Deok Ryun Kim; Mohammad Ali; Hyejon Lee; Xuanyi Wang; Vu Dinh Thiem; Do Gia Canh; Wanpen Chaicumpa; Magdarina D Agtini; Anowar Hossain; Zulfiqar A Bhutta; Carl Mason; Ornthipa Sethabutr; Kaisar Talukder; G B Nair; Jacqueline L Deen; Karen Kotloff; John Clemens
Journal:  PLoS Med       Date:  2006-09       Impact factor: 11.069

4.  Age-dependent association among Helicobacter pylori infection, serum pepsinogen levels and immune response of children to live oral cholera vaccine CVD 103-HgR.

Authors:  Khitam Muhsen; Rosanna Lagos; Mardi K Reymann; David Y Graham; Marcela F Pasetti; Myron M Levine
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

5.  The changing epidemiology of bacillary dysentery and characteristics of antimicrobial resistance of Shigella isolated in China from 2004-2014.

Authors:  Zhaorui Chang; Jing Zhang; Lu Ran; Junling Sun; Fengfeng Liu; Li Luo; Lingjia Zeng; Liping Wang; Zhongjie Li; Hongjie Yu; Qiaohong Liao
Journal:  BMC Infect Dis       Date:  2016-11-18       Impact factor: 3.090

6.  Attenuated Shigella flexneri 2a vaccine strain CVD 1204 expressing colonization factor antigen I and mutant heat-labile enterotoxin of enterotoxigenic Escherichia coli.

Authors:  H Koprowski; M M Levine; R J Anderson; G Losonsky; M Pizza; E M Barry
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

7.  Rapid diagnosis of diarrhea caused by Shigella sonnei using dipsticks; comparison of rectal swabs, direct stool and stool culture.

Authors:  Claudia Duran; Faridabano Nato; Sylvie Dartevelle; Lan Nguyen Thi Phuong; Neelam Taneja; Marie Noëlle Ungeheuer; Guillermo Soza; Leslie Anderson; Dona Benadof; Agustín Zamorano; Tai The Diep; Truong Quang Nguyen; Vu Hoang Nguyen; Catherine Ottone; Evelyne Bégaud; Sapna Pahil; Valeria Prado; Philippe Sansonetti; Yves Germani
Journal:  PLoS One       Date:  2013-11-22       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.